Lifespan Cancer Institute at Rhode Island Hospital

Providence, Rhode Island 02903

1 studies enrolling now · 5 studies all time

What they study most

Adenocarcinoma - Gastroesophageal Junction (GEJ), Adenocarcinoma of Lung, Adenocarcinoma of the Stomach, B-cell Acute Lymphoblastic Leukemia, Breast Cancer, CD19 Expressing Malignancies, Chronic Lymphocytic Leukemia, Endometrial Cancer, Fallopian Tube Carcinoma, Hematologic Malignancy, Leiomyosarcoma, Liposarcoma

Studies at this site

• Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) — Recruiting now
• NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — Stopped early
• Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation — Completed
• Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies — Completed
• Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers — Completed